Why Aphria (TSX:APHA) Stock Soared 33.6% Last Week

Aphria Inc (TSX:APHA)(NYSE:APHA) wasn’t having a strong year, but last week, all that changed when the stock got a big bump in price and now looks to be headed to over $10 a share.

Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Aphria (TSX:APHA)(NYSE:APHA) has typically been a laggard when it has come to cannabis stocks. However, last week, the stock came close to reaching $10 — a price it hasn’t hit since June.

What happened?

Aphria released its quarterly results last week, and it gave investors a pleasant surprise, as not only were sales up significantly, but the company also reported a profit as well.

Revenues of $128.6 million were up 75% from the prior quarter. A big reason for the improvement was that sales volumes were up for the quarter and Aphria also benefited from strong sales from CC Pharma, its German partner.

Without the benefit of distribution revenues propping up the company’s performance this past quarter, the increase would not have looked as impressive as it was. However, net cannabis revenue of $28.6 million for the quarter was still nearly double the $15.4 million that was generated back in Q3.

Net income of $15.8 million was probably a bigger surprise for the company, especially on the heels of Canopy Growth’s recent performance, which may have been the tipping point for co-CEO Bruce Linton being let go by the company. Investors have been placing a lot more importance and emphasis on the bottom line, and so it’s no surprise that Aphria’s results generated a lot of bullishness around the stock.

However, it should be noted that from an operating perspective, the company still reported a loss of $24 million during the quarter from its operations. Had it not been for non-operating income of $40 million boosting its results into the black, it would have still been a loss for the quarter.

What does this mean for Aphria?

With Aphria getting some momentum behind the stock, it could generate a lot more interest from investors going forward. Up more than 20% now since the start of the year, the stock was in the negative position prior to this latest push in price. This could be the start of a much bigger rally for a stock that generally has not seen a lot of excitement from cannabis investors.

These latest results could give Aphria some new life, at least until the next quarterly results. It’ll be important to see if in Q1 the company is able to build on these results and prove that it is a formidable stock to invest in or whether this was just a one-off performance.

Does this make the stock a buy?

Despite the strong results, I’d still be a bit hesitant to buy Aphria today. While the headlines will say that Aphria turned a profit and that it was a great result for the company, let’s not forget that it wasn’t due to its day-to-day operations.

I’m always wary of companies that need non-operating income to push them into the black. There’s no guarantee we’ll see that income in future quarters, and the company is not being profitable from its core business, which is still an area of concern for me.

While the stock may be a good buy today, and it could rally in price, I’d be careful is suggesting that this will all of a sudden make Aphria one of the top pot stocks to invest in.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »